1-4 of 4
Deyou Zheng
Close
Sort by
Journal Articles

PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation

Zhihong Ren, Jeong Hyun Ahn, Hequn Liu, Yi-Hsuan Tsai, Natarajan V. Bhanu, Brian Koss, David F. Allison, Anqi Ma, Aaron J. Storey, Ping Wang, Samuel G. Mackintosh, Ricky D. Edmondson, Richard W. J. Groen, Anton C. Martens, Benjamin A. Garcia, Alan J. Tackett, Jian Jin, Ling Cai, Deyou Zheng, Gang Greg Wang
Journal: Blood
Blood (2019) 134 (14): 1176–1189.
https://doi.org/10.1182/blood.2019000578
Published: 2019
Includes: Supplemental data
Journal Articles

Epigenetic Reprogramming of Cis-Regulatory Sites By R882 -Mutated DNMT3A Potentiates Aberrant Stem Cell Gene Program and Acute Leukemia Development

Rui Lu, PhD, Ping Wang, PhD, Trevor Parton, Deyou Zheng, PhD, Gang Greg Wang, PhD
Journal: Blood
Blood (2015) 126 (23): 2430.
https://doi.org/10.1182/blood.V126.23.2430.2430
Published: 2015
Journal Articles

Colony stimulating factor-1 receptor signaling networks inhibit mouse macrophage inflammatory responses by induction of microRNA-21

e-blood
Cristina I. Caescu, Xingyi Guo, Lydia Tesfa, Tushar D. Bhagat, Amit Verma, Deyou Zheng, E. Richard Stanley
Journal: Blood
Blood (2015) 125 (8): e1–e13.
https://doi.org/10.1182/blood-2014-10-608000
Published: 2015
Includes: Supplemental data
Journal Articles

Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL- rearranged leukemia

Bowen Xu, Doan M. On, Anqi Ma, Trevor Parton, Kyle D. Konze, Samantha G. Pattenden, David F. Allison, Ling Cai, Shira Rockowitz, Shichong Liu, Ying Liu, Fengling Li, Masoud Vedadi, Stephen V. Frye, Benjamin A. Garcia, Deyou Zheng, Jian Jin, Gang Greg Wang
Journal: Blood
Blood (2015) 125 (2): 346–357.
https://doi.org/10.1182/blood-2014-06-581082
Published: 2015
Includes: Supplemental data